Pyxis Oncology, Inc. (PYXS) — 10-Q Filings

10-Q Filings (6)

• Pyxis Oncology's Losses Mount, Cash Dwindles Amid R&D Spend — Nov 3, 2025 Risk: high
  Pyxis Oncology, Inc. reported a net loss of $61.5 million for the nine months ended September 30, 2025, a significant increase from the $41.8 million net loss f
• Pyxis Oncology's Losses Double Amid R&D Surge, Cash Dwindles — Aug 14, 2025 Risk: high
  Pyxis Oncology, Inc. reported a net loss of $39.5 million for the six months ended June 30, 2025, a significant increase from the $20.6 million net loss for the
• Pyxis Oncology Files Q1 2025 10-Q — May 15, 2025 Risk: medium
  Pyxis Oncology, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial condition and business operations, including det
• Pyxis Oncology Q3 2024 Update — Nov 12, 2024 Risk: medium
  Pyxis Oncology, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results and operational updates. Key events inc
• Pyxis Oncology Files Q2 2024 10-Q — Aug 14, 2024 Risk: medium
  Pyxis Oncology, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results and provided updates on its operations. Spec
• Pyxis Oncology Files 10-Q for Period Ending March 31, 2024 — May 14, 2024 Risk:
  Pyxis Oncology, Inc. (PYXS) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Pyxis Oncology, Inc. filed a 10-Q for the period ending March 31, 2024

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX